Adalimumab(Humira®) Pharmacokinetic ELISA
Catalog EL-1611-011

Product Properties

Detection method

Peroxidase / OD450 

Storage and stability

Stable at -20°C for 1 year 

Safety Warnings and Precautions

Research Use Only. Follow instructions. 


Intra-assay coefficient of variation (CV) <10%. Inter-assay CV <10%. 

Detection limit


Each kit includes:

Coated microtiter plate, 96 wells
Calibrator diluent. - 1.8ml
Calibrator (250 ug/mL) - 12ul
10X wash buffer - 25ml
Assay buffer - 50ml
1000X detection reagent - 17ul
TMB - 12ml
TMB stop solution - 12ml
Plate sealers - 3 



Adalimumab (Humira®) is a human monoclonal antibody used to block the action of tumor necrosis factor alpha (TNF-α). TNF-α is a strong proinflammatory cytokine involved in normal immunity and also various autoimmune diseases.
The Adalimumab ELISA kit is designed to measure free Adalimumab with high specificity and sensitivity. The assay design uses a pair of antibodies allowing detection of whole Adalimumab molecules in biological matrices.
This assay employs the sandwich enzyme immunoassay technique. Anti- Adalimumab is coated onto a 96 well microplate. Calibrator, quality control samples and test samples are pipetted into the appropriate wells. Adalimumab present in biological matrices is bound by the immobilized capture antibody. After washing away any unbound substances, enzyme linked detection antibody is added to the wells. The plate is washed to remove any unbound antibody-enzyme reagent and a substrate solution is added to the wells for color development. The color development is proportional to the amount of Adalimumab present in test samples.



There are no reviews yet.

Be the first to review “Adalimumab(Humira®) Pharmacokinetic ELISA
Catalog EL-1611-011”

Your email address will not be published. Required fields are marked *